ContextVision announces appointment of Gerald Pötzsch as new CEO

ContextVision, Home, Investor News, News 2022-05-13
ContextVision, the world’s leading Image enhancement provider is pleased to announce the appointment of Gerald Pötzsch as Chief Executive Officer, effective 1st of August 2022. Gerald has solid academic and professional background, holding doctor’s degrees both in Engineering and Medicine and 16 years with Philips Medical imaging business. “This will be a good addition to the […]
Read More

ContextVision Annual General Meeting

ContextVision, Home, Investor News, News 2022-05-04
On the 4th of May 2022, ContextVision held its ordinary Shareholders’ Annual General Meeting in Stockholm. Major items approved by the Annual General Meeting include: The annual financial report regarding 2021 was approved by the AGM. Disposition of financial results according to the proposal of the Board of Directors was approved. The Managing Director and […]
Read More

ContextVision – Invitation to Annual General Meeting 2022

ContextVision, Digital Pathology, Home, Investor News, News 2022-03-31
STOCKHOLM – March 31, 2022 – ContextVision hereby invites shareholders to the Annual General Meeting on May 4, 2022. Please find attached the invitation including agenda and details on how to register and vote. Please contact: for any questions regarding the AGM. For inquiries, please contact CFO Markus Hökerberg E-mail:
Read More

ContextVision presents Annual Report 2021

Annual reports, ContextVision, Digital Pathology, Home, Investor News, News 2022-03-31
STOCKHOLM – March 31, 2022 – Please find ContextVision’s Annual Report 2021 attached. The report can also be found on the company’s website: www.contextvision.se Printed copies of the report will be distributed upon request by e-mail: For inquiries, please contact CFO Markus Hökerberg E-mail: ### About ContextVision ContextVision is a medical technology software company […]
Read More

ContextVision shows strong momentum in Q4, leading to record sales for the year

ContextVision, Financial reports, Home, Investor News, News 2022-02-17
STOCKHOLM – Feb 16, 2022- ContextVision, a medical technology software company specializing in image processing, image analysis and decision support tools for digital pathology, today reports its fourth quarter and full year 2021 results. Total sales 2021 reached 98.1 MSEK (94.7), which is the highest revenue in the history of the company. After a slow […]
Read More

ContextVision Announces New Leadership Team, Appoints Ola Lindblad as CEO

ContextVision, Home, News 2022-02-14
STOCKHOLM – February 14, 2022 – ContextVision, a medical technology software company specializing in image quality and artificial intelligence, announces a new executive leadership team following the spin out of the company’s digital pathology arm into a new standalone business. Previous leaders at ContextVision will assume new roles, including the appointment of Ola Lindblad as […]
Read More

ContextVision – Information regarding dividend and reverse share split in Inify Laboratories

ContextVision, Digital Pathology, Home, Investor News, News 2022-02-11
ContextVision AB (“ContextVision” or the “Company”) will, in accordance with the press release published on 2 February 2022, distribute all shares in its wholly-owned subsidiary INIFY Laboratories AB (“INIFY”) to the shareholders of ContextVision. The shares in INIFY are expected to be delivered to shareholders who have their shares registered at Euroclear Sweden AB around […]
Read More